免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

STA® - Liatest® D-Di

K 號:K162227 · 2016-12-10

決定日期2016-12-10
產品代碼DAP
諮詢委員會HE 請提供完整的描述文本,以便我能夠進行翻譯。
決定相當於

器材摘要

STA® - Liatest® D-Di is the device name listed in this FDA 510(k) record. The listed applicant is Diagnostica Stago. It received FDA 510(k) clearance on 2016-12-10 under 510(k) number K162227. The device is classified under product code DAP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the STA® - Liatest® D-Di?

STA® - Liatest® D-Di is a medical device that received FDA 510(k) clearance on 2016-12-10. The listed applicant is Diagnostica Stago. The 510(k) number is K162227.

When did STA® - Liatest® D-Di receive FDA 510(k) clearance?

STA® - Liatest® D-Di received FDA 510(k) clearance on 2016-12-10, under 510(k) number K162227.

Who is the listed applicant for STA® - Liatest® D-Di?

The FDA 510(k) record lists Diagnostica Stago as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for STA® - Liatest® D-Di?

The FDA product code for STA® - Liatest® D-Di is DAP.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DAP)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑